2 ASX AI shares that could be set to soar in 2024 and beyond

Analysts think these shares with AI exposure are top buys and destined for strong growth.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share market has been getting very excited about the artificial intelligence (AI) megatrend this year.

And rightly so. It's no exaggeration to say that AI is going to change the world.

We've only really had a small taste of this in the last few years but expect things to accelerate as AI continues to improve and more money is invested in the space.

The good news for investors is that there are ways to gain exposure to AI with ASX shares.

And I don't mean with supposed AI shares like Brainchip Holdings Ltd (ASX: BRN), which has promised the world and delivered nothing in a market dominated by a US$3 trillion behemoth.

I mean with genuine industry leaders that are leveraging AI to cement their position and drive long-term growth. Let's take a look at two:

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares

Image source: Getty Images

Pro Medicus Limited (ASX: PME)

The first ASX AI share to look at is health imaging technology company Pro Medicus,

Goldman Sachs recently spoke about how the company's AI revenues could grow from a small percentage of its overall sales into something significant in the future. It said:

AI opens an incremental US$620mn TAM today (growing at a +34.7% CAGR) with radiology receiving the majority (c.80%) of recent FDA AI algorithm clearance. We believe PME is well positioned to take share as the incumbent viewing platform across many large, and likely early adopters of new technology.

PME is generating revenue from its Visage breast density AI algorithm (developed via a partnership with Yale) today, and we see the potential value for AI to be significant with adoption driven by improved accuracy and clinical outcomes. We forecast AI to comprise 9% of PME's revenue by FY30E (from <1% in FY25E), with upside if PME achieves faster AI attach penetration, higher price per scan, and a greater proportion of algorithms developed in-house where no royalties are paid to a partner.

Goldman has a buy rating and $136.00 price target on its shares.

NextDC Ltd (ASX: NXT)

Another ASX AI share to look at is data centre operator NextDC. While it isn't necessarily offering AI services, it is servicing the huge data centre demand for capacity that AI needs to function.

In April, Goldman Sachs commented on this. It said:

NextDC believes AI is driving global data centre growth from 15% to 19% with Australia and broader APAC remaining well-positioned for growth and the fastest growing region. AI is increasing average power density racks (kW/Rack) growing 2.5x to c80-100kW. NXT are seeing demand pipeline for singular deals in the vicinity of 50-100MW and see market growth accelerating. AI demand is also stemming from a 40%/60% mix from inference/training, with upside for inference to reach 70%.

The broker currently has a buy rating and $18.59 price target on its shares. Though, it is worth noting that other brokers are even more bullish. For example, Morgan Stanley has an overweight rating and $20.00 price target.

Motley Fool contributor James Mickleboro has positions in Nextdc and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.
Technology Shares

These beaten down ASX 200 tech stocks could rise 55% to 60%

Brokers think these stocks could rise strongly from current levels.

Read more »

Hand with AI in capital letters and AI-related digital icons.
Technology Shares

Which junior ASX AI company has rocketed almost 40% on a transformational deal?

Big things could come from this deal, the company's leaders say.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Technology Shares

Up 13% today. Here's why this $6.6 billion ASX stock is on the move again

Codan shares rocket as earnings guidance jumps more than 60%

Read more »

a man raises his fists to the air in joyous celebration while learning some exciting good news via his computer screen in an office setting.
Technology Shares

Codan FY26 earnings surge more than 60% on strong communications segment

Codan expects FY26 EBIT and NPAT to surge by more than 60%, powered by strong results in both communications and…

Read more »

Two smiling work colleagues discuss an investment at their office.
Technology Shares

Down 30%, why this ASX 200 stock could be a strong buy

A sharp pullback has changed the starting point. The key question now is whether the growth and scalability story still…

Read more »

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Technology Shares

Why Bell Potter says this ASX defence stock could rocket 100%

Bell Potter thinks this speculative stock could double in value.

Read more »

A man flying a drone using a remote controller.
Technology Shares

Up 133% this year and still climbing: Why this ASX tech stock just hit a record high

This ASX tech stock just hit a record high after an exciting US defence update.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Technology Shares

Could buying Xero shares at $80 make me rich?

After a major pullback, could this be a turning point for long-term investors? I dig deeper into things in this…

Read more »